ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combinations in Pts With Adv/Metastatic HER2+ Esophageal, Gastric, or GEJ Adenocarcinoma | VuMedi

Find latest Gastric Cancer videos · 100+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: DESTINY-Gastric03 - T-DXd Monotherapy and Combinations in Pts With Adv/Metastatic HER2+ Esophageal, Gastric, or GEJ Adenocarcinoma

By 2024 ESMO Annual Meeting Insights Hub FEATURING Yelena Janjigian

By 2024 ESMO Annual Meeting Insights Hub FEATURING Yelena Janjigian

157 views

October 2, 2024

Comments 0

Login to view comments. Click here to Login